Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06712693 · ClinicalTrials.gov registry record · NA
Venting Effects on Speech Performance
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT06712693: Completed NA study, sponsored by Sonova.
NCT06712693 is a NA study that has completed, run by Sonova. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06712693, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study aims to gather behavioral data on the effect of earmold venting on speech performance in noise with a new noise reduction feature.
Primary Outcome
Sentences will be presented at a pre-determined Signal-to-Noise Ratio (SNR). The SNR will be the same for all three conditions (Power dome, Vented dome, Open dome). Percent correct will be calculated for all conditions. A higher percentage indicates better performance.
Interventions
- DEVICE Phonak Audeo Infinio Hearing Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2025-01-23 |
| Phase | NA |
What the finished NCT06712693 record still lists
NCT06712693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Phonak Audeo Infinio Hearing Aid is the first listed.
NCT06712693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06712693 about?
NCT06712693 is a clinical study titled "Venting Effects on Speech Performance". This study aims to gather behavioral data on the effect of earmold venting on speech performance in noise with a new noise reduction feature.
What is the current status of trial NCT06712693?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2024-11-11. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT06712693?
The interventions under investigation include: Phonak Audeo Infinio Hearing Aid (DEVICE).
Who is sponsoring clinical trial NCT06712693?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06712693's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI